Cargando…
Xuezhikang reduced arterial stiffness in patients with essential hypertension: a preliminary study
This study aimed to test the effects of xuezhikang, a cholestin extract that contains statin-like components, on arterial stiffness in patients with essential hypertension. One hundred hypertensive patients from the Chinese PLA General Hospital were randomly allocated to receive xuezhikang (1200 mg/...
Autores principales: | Zheng, J., Xiao, T., Ye, P., Miao, D., Wu, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579967/ https://www.ncbi.nlm.nih.gov/pubmed/28876367 http://dx.doi.org/10.1590/1414-431X20176363 |
Ejemplares similares
-
Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels
por: Cao, Ruihua, et al.
Publicado: (2021) -
Xuezhikang Therapy Increases miR-33 Expression in Patients with Low HDL-C Levels
por: Cao, Ruihua, et al.
Publicado: (2014) -
Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans
por: Xu, Rui-Xia, et al.
Publicado: (2017) -
The Effect of Telmisartan on Endothelial Function and Arterial Stiffness in Patients With Essential Hypertension
por: Jung, An Doc, et al.
Publicado: (2009) -
Effects of Xuezhikang versus Pravastatin on Triglyceride Level in Patients with T2DM and Dyslipidemia: Study Protocol for a Multicenter Randomized Controlled Trial
por: Xu, Jin, et al.
Publicado: (2023)